|
|
Volumn 31, Issue 5, 2013, Pages 373-
|
|
Second oral MS drug wins FDA nod.
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
FUMARIC ACID DERIVATIVE;
FUMARIC ACID DIMETHYL ESTER;
IMMUNOSUPPRESSIVE AGENT;
DRUG APPROVAL;
DRUG INDUSTRY;
ECONOMICS;
HUMAN;
MULTIPLE SCLEROSIS;
NOTE;
ORAL DRUG ADMINISTRATION;
UNITED STATES;
ADMINISTRATION, ORAL;
DRUG APPROVAL;
DRUG INDUSTRY;
FUMARATES;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
MULTIPLE SCLEROSIS;
UNITED STATES;
|
|
EID: 84886525826
PISSN: None
EISSN: 15461696
Source Type: None
DOI: 10.1038/nbt0513-373a Document Type: Note |
|
Times cited : (6)
|
|
References (0)
|
